A new schedule of CHOP/Rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation

Attilio Olivieri, Moira Lucesole, Debora Capelli, Guido Gini, Mauro Montanari, Marco Candela, Emanuela Troiani, Ilaria Scortechini, Antonella Poloni, Pietro Leoni

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A new schedule of CHOP/Rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences